Please assess the completion status of the following clinical trial:

Trial Title: Ultra-low-dose CACS in a Large Population

Study Design Characteristics:
- Allocation: None
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients referred for a non-contrast enhanced CT scan for CAC scoring~* Male and Female subjects ≥18 years of age,~* Written informed consent~Exclusion Criteria:~* Pregnancy or breast-feeding~* CACS of 0 after inclusion of 50 patients with CACS 0 (as assessed visually after the first CT scan, prior to performing the 3 additional study scans)~* History of coronary artery stenting, coronary artery bypass grafting, of implantation of cardiac devices (e.g. valve prosthesis, pacemaker, implantable cardioverter defibrillator etc.)~* Enrolment of the investigator, his/her family members, employees and other dependent persons

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard and ultra-low-dose CAC scoring (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).